Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905

Lignende værker

• Augmented Therapy Improves Outcome For Pediatric High Risk Acute Lymphocytic Leukemia: Results Of Children’s Oncology Group Trial P9906
  af: Bowman, W. Paul, et al.
  Udgivet: (2011)
• Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: A report from the Children’s Oncology Group
  af: Tower, Richard L., et al.
  Udgivet: (2014)
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
  af: Borowitz, Michael J., et al.
  Udgivet: (2008)
• Long-term Results Of the Pediatric Oncology Group Studies For Childhood Acute Lymphoblastic Leukemia 1984-2001: A Report From The Children’s Oncology Group
  af: Salzer, Wanda L., et al.
  Udgivet: (2009)
• Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group
  af: Maloney, Kelly W., et al.
  Udgivet: (2010)